Table 2.
Survival outcomes and relapses.
| Number | % | |
|---|---|---|
| Follow-up duration, months | ||
| Median (range) | 13.3 (0.8–87.1) | |
| Overall survival (OS) | ||
| Events/patients | 18/50 | |
| Median OS, months (95% CI) | 28.8 (18.3–39.1) | |
| 1-year OS, % (95% CI) | 87.6 (72.7–94.7) | |
| Progression-free survival (PFS) | ||
| Events/patients | 33/50 | |
| Median PFS, months (95% CI) | 9.4 (7.7–13.9) | |
| 1-year PFS, % (95% CI) | 37.6 (22.7–52.5) | |
| Among relapsed patients | 32 | 100.0 |
| Site of relapse | ||
| Peritoneum | 28 | 87.5 |
| Lymph nodes | 11 | 34.4 |
| Lung | 15 | 46.9 |
| Liver | 8 | 25.0 |
| Bones | 5 | 15.6 |
| Others | 8 | 25.0 |
CI, confidence interval.